Corrigendum to "Drug screening identifies aldose reductase as a novel target for treating cisplatin-induced hearing loss" [Free Radic. Biol. Med. 210 (2024) 430-447].

Free Radic Biol Med

Department of Otorhinolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230031, PR China; Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, PR China; NHC Key Laboratory of Hearing Medicine (Fudan University), Shanghai, 200031, PR China; The Institutes of Brain Science and the Collaborative Innovation Center for Brain Science, Fudan University, Shanghai, 200032, PR China; ENT Institute and Otorhinolaryngology Department of Eye & ENT Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University, Shanghai, 200031, PR China. Electronic address:

Published: March 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.freeradbiomed.2024.01.040DOI Listing

Publication Analysis

Top Keywords

corrigendum "drug
4
"drug screening
4
screening identifies
4
identifies aldose
4
aldose reductase
4
reductase novel
4
novel target
4
target treating
4
treating cisplatin-induced
4
cisplatin-induced hearing
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!